Plasma haptoglobin as a potential biomarker for coronary artery disease in young hypertensive adults

Uncontrolled hypertension is one of the recognized risk factors for coronary artery disease (CAD) in young adults, commonly underestimated owing to the young age. A novel biomarker to improve CAD risk assessment and hypertension management should be identified for this cohort. Thus, we had conducted...

Full description

Bibliographic Details
Main Authors: Norbaiyah, Mohamed Bakrim, Wan Fatein Nabeila, Wan Omar, Aszrin, Wan Abdullah, Nurul Nadiah, Hamidon, Suhaila, Abdul Muid, A., Badrulhisham
Format: Article
Language:English
English
Published: International Islamic University Malaysia 2024
Subjects:
Online Access:http://umpir.ump.edu.my/id/eprint/41279/1/Plasma%20haptoglobin%20as%20a%20potential%20biomarker%20for%20coronary%20artery%20disease.pdf
http://umpir.ump.edu.my/id/eprint/41279/2/Plasma%20haptoglobin%20as%20A%20potential%20biomarker%20for%20coronary%20artery%20disease%20in%20young%20hypertensive%20adults_Abs.pdf
Description
Summary:Uncontrolled hypertension is one of the recognized risk factors for coronary artery disease (CAD) in young adults, commonly underestimated owing to the young age. A novel biomarker to improve CAD risk assessment and hypertension management should be identified for this cohort. Thus, we had conducted a study to investigate plasma concentration and the role of haptoglobin in young hypertensive adults in the establishment of premature acute myocardial infarction (AMI). MATERIALS AND METHODS: A total of 120 male adults aged between 18 to 45 years enrolled into this cross-sectional study, divided into control, hypertensive, and acute myocardial infarction (AMI) groups. Blood samples were collected from all subjects, plasma concentrations of haptoglobin measured using enzyme-linked immunosorbent assays, and other CAD risk factors including high sensitivity C-reactive protein (hs-CRP) levels were analyzed. RESULTS: Plasma concentration of haptoglobin in the AMI group was the highest compared to hypertensive and control group (290.63±99.90 vs. 208.47±112.93 vs. 170.02±108.11 ng/ml, p<0.006). There was a significant association between AMI and plasma haptoglobin concentration in hypertensive subjects independent of other known CAD risk factors (OR: 0.985, 95% CI 0.973-0.997, p=0.017). There was positive correlation between plasma haptoglobin and hs-CRP (r=0.0370, p<0.001). CONCLUSION: Plasma haptoglobin is a potential biomarker to identify young hypertensive adults who are at risk of developing CAD.